Akebia Therapeutics, Inc.

Q3 2022 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filers
94
Total reported value, excl. options
$16.5M
Manager Report Date Value ($000) Shares